Francesco Perrone
Francesco Perrone
Istituto Nazionale Tumori di Napoli
Verified email at
TitleCited byYear
Design and endpoints of clinical trials in hepatocellular carcinoma
JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ...
Journal of the National Cancer Institute 100 (10), 698-711, 2008
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial
C Gridelli, F Perrone, C Gallo, S Cigolari, A Rossi, F Piantedosi, ...
Journal of the National Cancer Institute 95 (5), 362-372, 2003
Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer
T Elderly Lung Cancer Vinorelbine Italian Study Group
Journal of the National Cancer Institute 91 (1), 66-72, 1999
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
C Carlomagno, F Perrone, C Gallo, M De Laurentiis, R Lauria, A Morabito, ...
Journal of Clinical Oncology 14 (10), 2702-2708, 1996
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non—small-cell lung cancer receiving …
P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ...
Journal of Clinical Oncology 23 (28), 6865-6872, 2005
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
N Normanno, M Di Maio, E De Maio, A De Luca, A de Matteis, A Giordano, ...
Endocrine-related cancer 12 (4), 721-747, 2005
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non–small-cell lung cancer: A phase III trial of the Italian …
C Gridelli, C Gallo, FA Shepherd, A Illiano, F Piantedosi, SF Robbiati, ...
Journal of clinical oncology 21 (16), 3025-3034, 2003
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study
G Colucci, R Labianca, F Di Costanzo, V Gebbia, G Carteń, B Massidda, ...
Journal of Clinical Oncology 28 (10), 1645-1651, 2010
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions
A Morabito, E De Maio, M Di Maio, N Normanno, F Perrone
The Oncologist 11 (7), 753-764, 2006
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators
CLIP Group
Hepatology 28, 751-755, 1998
Treatment of advanced non–small-cell lung cancer in the elderly: Results of an international expert panel
C Gridelli, M Aapro, A Ardizzoni, L Balducci, F De Marinis, K Kelly, ...
Journal of Clinical Oncology 23 (13), 3125-3137, 2005
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial
C Gridelli, F Ciardiello, C Gallo, R Feld, C Butts, V Gebbia, P Maione, ...
J Clin Oncol 30 (24), 3002-3011, 2012
Lung cancer in the elderly
C Gridelli
Eur J Cancer 33, 2313-2314, 1997
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
M Di Maio, C Gridelli, C Gallo, F Shepherd, FV Piantedosi, S Cigolari, ...
The lancet oncology 6 (9), 669-677, 2005
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer
M Di Maio, P Chiodini, V Georgoulias, D Hatzidaki, K Takeda, ...
J Clin Oncol 27 (11), 1836-43, 2009
Carboplatin-or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
A Rossi, M Di Maio, P Chiodini, RM Rudd, H Okamoto, DV Skarlos, ...
Journal of Clinical Oncology 30 (14), 1692-1698, 2012
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer
R Lauria, F Perrone, C Carlomagno, M De Laurentiis, A Morabito, C Gallo, ...
Cancer 76 (10), 1772-1778, 1995
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
C Gridelli, C Gallo, M Di Maio, E Barletta, A Illiano, P Maione, S Salvagni, ...
British Journal of Cancer 91 (12), 1996, 2004
Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial
B Daniele, F Perrone, C Gallo, S Pignata, S De Martino, R De Vivo, ...
Gut 48 (1), 28-33, 2001
The system can't perform the operation now. Try again later.
Articles 1–20